Tetrac - HY-W008859
Nur noch %1 verfügbar
Catalog #
HY-W008859
Ab
33,00 €
Tetrac (Tetraiodothyroacetic acid), a derivative of L-thyroxine (T4), is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T4 and 3,5,3'-triiodo-L-thyronine (T3) at the cell surface receptor for thyroid hormone on integrin αvβ3. Tetra has anti-angiogenic and anti-tumor activities[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-W008859/Tetrac-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | Tetraiodothyroacetic acid; 3,3',5,5'-Tetraiodothyroacetic acid |
| CAS | 67-30-1 |
| Storage | -20°C (Powder, protect from light) |
| MWT | 747.83 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Endogenous Metabolite;Integrin |
| Application: | Cancer-programmed cell death |
|---|